Literature DB >> 21913917

Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation.

Luisa De Gennaro1, Natale Daniele Brunetti, Deodata Montrone, Fiorella De Rosa, Andrea Cuculo, Matteo Di Biase.   

Abstract

BACKGROUND: Atrial fibrillation (AF) might be associated with an inflammatory activation and reduced left ventricular (LV) function. Less is known with regard to newly introduced markers of LV dysfunction such as carbohydrate antigen-125 (CA-125) in subjects with AF. The aim of this study was therefore to assess possible associations between AF, inflammatory markers and CA-125. METHODS AND
RESULTS: Forty-eight consecutive patients with AF and 58 control patients in sinus rhythm were enrolled in this study. Patients with acute heart failure, chronic inflammatory or neoplastic disease were excluded from the study. Circulating levels of hs-C-reactive protein (CRP), interleukin-8 (IL-8), IL-6, soluble IL-2 receptor (sIL-2r), TNF-α and CA-125 were assessed; all patients underwent clinical examination with NYHA class assessment and echocardiography. Patients with AF were characterised by higher levels of IL-8 (180 ± 266 vs. 39 ± 43 pg/mL, P < 0·001), sIL-2r (987 ± 1045 vs. 680 ± 336 U/mL, P < 0·05) and TNF-α (26 ± 25 vs. 9 ± 4 pg/mL, P < 0·001). Patients with AF duration < 6 months had higher levels of CRP (54 ± 73 vs. 12 ± 14 mg/dL, P < 0·05) and IL-8 (251 ± 225 vs. 99 ± 123 pg/mL, P < 0·05) when compared with AF duration > 6 months. CA-125 levels were not statistically different if comparing subjects with AF with controls and AF > 6 months with AF < 6 months. Among patients with AF, CA-125 levels were significantly related to NYHA class, (r = 0·33, P < 0·05) as well as IL-6 levels (r = 0·31, P < 0·05). Results remained statistically significant even after multivariable correction for age, gender and LV ejection fraction. RESULTS AND
CONCLUSION: AF is characterised by an inflammatory activation. Impaired functional class in AF subjects might be associated with increased CA-125 levels and higher inflammatory markers.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913917     DOI: 10.1111/j.1365-2362.2011.02592.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

1.  Carbohydrate-antigen-125 levels predict hospital stay duration and adverse events at long-term follow-up in Takotsubo cardiomyopathy.

Authors:  Francesco Santoro; Armando Ferraretti; Francesco Musaico; Luigi Di Martino; Nicola Tarantino; Riccardo Ieva; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Intern Emerg Med       Date:  2016-02-01       Impact factor: 3.397

2.  Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure.

Authors:  Hakki Kaya; Recep Kurt; Osman Beton; Ali Zorlu; Hasan Yucel; Hakan Gunes; Didem Oguz; Mehmet Birhan Yilmaz
Journal:  Tex Heart Inst J       Date:  2017-02-01

3.  Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer.

Authors:  Babatunde O Akinwunmi; Ana Babic; Allison F Vitonis; Daniel W Cramer; Linda Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09-20       Impact factor: 4.254

4.  Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation.

Authors:  H Yucel; H Kaya; A Zorlu; K Yıldırımlı; E Sancakdar; H Gunes; R Kurt; U Ozgul; O O Turgut; M B Yilmaz
Journal:  Herz       Date:  2014-09-27       Impact factor: 1.443

Review 5.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

6.  Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

Authors:  Mohamed L Sorror; Paul J Martin; Rainer F Storb; Smita Bhatia; Richard T Maziarz; Michael A Pulsipher; Michael B Maris; Christopher Davis; H Joachim Deeg; Stephanie J Lee; David G Maloney; Brenda M Sandmaier; Frederick R Appelbaum; Theodore A Gooley
Journal:  Blood       Date:  2014-05-05       Impact factor: 22.113

7.  Syndecan-4 shedding is involved in the oxidative stress and inflammatory responses in left atrial tissue with valvular atrial fibrillation.

Authors:  Han Wu; Qing Zhou; Jun Xie; Guan-Nan Li; Qin-Hua Chen; Li-Na Kang; Biao Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

8.  Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis.

Authors:  Angel Cheung; Mengqi Gong; Roberto Bellanti; Sadeq Ali-Hasan-Al-Saegh; Guangping Li; Eulàlia Roig; Julio Núñez; Thomas D Stamos; Mehmet Birhan Yilmaz; Kaya Hakki; William K K Wu; Sunny Hei Wong; Wing Tak Wong; George Bazoukis; Konstantinos Lampropoulos; Lah Ah Tse; Jichao Zhao; Gregory Y H Lip; Adrian Baranchuk; Martin C S Wong; Tong Liu; Gary Tse
Journal:  Heart Asia       Date:  2018-01-07

9.  Higher carbohydrate antigen 125 levels are associated with increased risk of coronary heart disease in elderly chinese: a population-based case-control study.

Authors:  Xiaorong Li; Meian He; Jiang Zhu; Ping Yao; Xiulou Li; Jing Yuan; Xinwen Min; Mingjian Lang; Handong Yang; Frank B Hu; Tangchun Wu; Sheng Wei
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

10.  Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.

Authors:  Haruki Sekiguchi; Ken Shimamoto; Mayu Takano; Makiko Kimura; Yufuko Takahashi; Fujio Tatsumi; Eri Watanabe; Kentaro Jujo; Naoko Ishizuka; Masatoshi Kawana; Nobuhisa Hagiwara
Journal:  Heart       Date:  2017-03-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.